These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control. Radermecker RP; Renard E; Scheen AJ Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088 [TBL] [Abstract][Full Text] [Related]
3. Insulin autoantibodies and insulin antibodies have similar binding characteristics. Brooks-Worrell BM; Nielson D; Palmer JP Proc Assoc Am Physicians; 1999; 111(1):92-6. PubMed ID: 9893161 [TBL] [Abstract][Full Text] [Related]
4. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term. Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235 [TBL] [Abstract][Full Text] [Related]
5. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225 [TBL] [Abstract][Full Text] [Related]
6. [Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus]. Rosas Vargas MA; Alvarez Amador M; Alvarez Amador LM; del Río Navarro BE; Avila Castanón L; Sienra Monge JJ Rev Alerg Mex; 2001; 48(5):129-32. PubMed ID: 11759253 [TBL] [Abstract][Full Text] [Related]
7. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258 [TBL] [Abstract][Full Text] [Related]
8. Current status and future of implantable insulin pumps for the treatment of diabetes. Catargi B Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038 [TBL] [Abstract][Full Text] [Related]
9. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389 [TBL] [Abstract][Full Text] [Related]
10. The role of inhaled insulin in the treatment of type 2 diabetes. Davis SN J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196 [TBL] [Abstract][Full Text] [Related]
12. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy. Shalitin S; Phillip M Diabetes Care; 2008 Feb; 31 Suppl 2():S121-4. PubMed ID: 18227471 [TBL] [Abstract][Full Text] [Related]
13. Insulin pump therapy (continuous subcutaneous insulin infusion). White RD Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820 [TBL] [Abstract][Full Text] [Related]
14. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. Hummel M; Durinovic-Bello I; Ziegler AG J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982 [TBL] [Abstract][Full Text] [Related]
15. Management of pregnancy in women with type 1 diabetes. Azar M; Lyons TJ Minerva Endocrinol; 2013 Dec; 38(4):339-49. PubMed ID: 24285102 [TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia risk reduction in type 1 diabetes. Cryer PE Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S412-23. PubMed ID: 11460588 [TBL] [Abstract][Full Text] [Related]
17. [Advantages and drawbacks of human insulin]. Zenobi PD Schweiz Med Wochenschr; 1991 Apr; 121(14):475-81. PubMed ID: 2035004 [TBL] [Abstract][Full Text] [Related]
18. Exogenous insulin autoimmune syndrome: A case report and review of literature. Xu LL; Chen JX; Cheng JP; Luo N World J Clin Cases; 2024 Mar; 12(9):1691-1697. PubMed ID: 38576740 [TBL] [Abstract][Full Text] [Related]
19. Insulin pump therapy in adults. Didangelos T; Iliadis F Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741 [TBL] [Abstract][Full Text] [Related]
20. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus. Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]